TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3062042

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 169

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 169
Study: 30439760

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (200 mL daily with Lactobacillus acidophilus La‐5, Bifidobacterium animalis subsp. lactis Bb‐12, Lactobacillus casei subsp. casei Lc‐01)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo yogurt (200 mL daily with Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Unblinded control (no yogurt)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Combined blinded study groups (probiotic and placebo)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 314
Study: 28792997

Group type: EXPERIMENTAL
Intervention: Hyoscine
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 25729066

Group type: EXPERIMENTAL
Intervention: Surgical treatment (combined superficial and perforating vein surgery)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Ambulatory compression therapy
Number of subjects: 196
Study: 23995464

Group type: EXPERIMENTAL
Intervention: Self-regulated, home-based exercise program
Number of subjects: 11
Study: 20110162

Group type: EXPERIMENTAL
Intervention: Field in field (FIF) technique
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non field in field - normalization to isodose line (NFIF-I)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Non field in field - normalization to target volume (NFIF-V)
Number of subjects: 12
Study: 19327948

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 40
Study: 18220219

Group type: EXPERIMENTAL
Intervention: Biolight therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 60
Study: 15292326

Group type: EXPERIMENTAL
Intervention: Hormone therapy for 6 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (age- and body mass index-matched premenopausal women; n=20)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate-induced vasodilation
Number of subjects: 18
Study: 11562652

Group type: EXPERIMENTAL
Intervention: New radiographic measurement method for axial rotation (Ry)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: New radiographic measurement method for lateral bending (Rz)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: New axial rotation method applied to a C3 plastic model
Number of subjects: 3
Study: 9065293

Group type: EXPERIMENTAL
Intervention: Electrocardiographic (ECG) technique
Number of subjects: 1822

Group type: COMPARATOR
Intervention: Fluoroscopy technique
Number of subjects: 1822
Study: 8202242

Group type: EXPERIMENTAL
Intervention: Home visits by military nurses (9 visits over 3 months)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no home visits)
Number of subjects: 75
Study: 3310625

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Sucralfate 1 g four times daily
Number of subjects: 258

Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 258
Study: 30646266

Group type: EXPERIMENTAL
Intervention: Children's Healthy Living Program (intervention group)
Number of subjects: 8371
Study: 28340625

Group type: EXPERIMENTAL
Intervention: Habit training with computer-assisted direct visual biofeedback (HTBF)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Habit training (HT)
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Investigation-led allocation (INVEST) to either HT or HTBF
Number of subjects: 394

Group type: COMPARATOR
Intervention: No-investigation allocation (No-INVEST)
Number of subjects: 394
Study: 26132393

Group type: EXPERIMENTAL
Intervention: pravastatin 40mg
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: simvastatin 20mg
Number of subjects: 1016

Group type: COMPARATOR
Intervention: statins (combined)
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: statins (especially simvastatin)
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: statins (in postmenopausal women)
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: statins (in postmenopausal women aged ≥45)
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: statins (in women with low baseline aggression)
Number of subjects: 1016
Study: 23967083

Group type: EXPERIMENTAL
Intervention: 15% DEET lotion
Number of subjects: 7979

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 7979
Study: 21679156

Group type: EXPERIMENTAL
Intervention: Cerebrolysin (10 ml)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Combination of Cerebrolysin and Donepezil
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 197
Study: 19480294

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 0
Study: 16603032

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) plus medication (fluvoxamine)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Medication (fluvoxamine)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 14675083

Group type: EXPERIMENTAL
Intervention: melagatran/ximelagatran
Number of subjects: 2835

Group type: COMPARATOR
Intervention: enoxaparin
Number of subjects: 2835
Study: 10832254

Group type: EXPERIMENTAL
Intervention: Amalgam restorations with adhesive liner
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amalgam restorations with copal varnish and zinc phosphate cement
Number of subjects: 0
Study: 8876403

Group type: EXPERIMENTAL
Intervention: Intervention programme involving a new approach to decision-making concerning long-term care of dependent elderly patients, including an early discharge planning service and an extended home care programme.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention programme involving a new approach to decision-making concerning long-term care of dependent elderly patients.
Number of subjects: 0
Study: 1291393

Group type: EXPERIMENTAL
Intervention: Dentin bonding resin groups
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Glass ionomer‐based restorations
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Resin-based bonding systems
Number of subjects: 100
Study: 12267101

Group type: EXPERIMENTAL
Intervention: Venotonic
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31533551

Group type: EXPERIMENTAL
Intervention: Patients with VTE
Number of subjects: 331950
Study: 29437981

Group type: EXPERIMENTAL
Intervention: Second-generation hydrogel coils
Number of subjects: 484

Group type: COMPARATOR
Intervention: Bare platinum coils (Control)
Number of subjects: 484
Study: 26608333

Group type: EXPERIMENTAL
Intervention: Get Busy Get Better (GBGB) intervention
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (delayed intervention)
Number of subjects: 208
Study: 24880753

Group type: EXPERIMENTAL
Intervention: Almorexant 200mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Desipramine 50mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Almorexant 200mg + Desipramine 50mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 22417901

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) - 1 g loading dose infused over 10 minutes followed by 1 g intravenous infusion over 8 hours
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 270
Study: 21058191

Group type: EXPERIMENTAL
Intervention: High-dose isoflavone supplement (450 mg genistein, 300 mg daidzein) daily for 6 months
Number of subjects: 53
Study: 17558828

Group type: EXPERIMENTAL
Intervention: Genetic testing consent process
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Participants who consented to genetic analysis
Number of subjects: 755
Study: 15090073

Group type: EXPERIMENTAL
Intervention: 15-week relaxation response intervention
Number of subjects: 134
Study: 11212979

Group type: EXPERIMENTAL
Intervention: Indapamide SR 1.5 mg
Number of subjects: 524

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 524

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Indapamide SR 1.5 mg (in ISH subgroup)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Amlodipine 5 mg (in ISH subgroup)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Amlodipine (in ISH subgroup)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (in ISH subgroup)
Number of subjects: 524
Study: 9707454

Group type: EXPERIMENTAL
Intervention: Salbutamol pMDI 100 microg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Salbutamol pMDI 200 microg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Salbutamol pMDI 400 microg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Salbutamol pMDI 800 microg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Salbutamol Turbuhaler 50 microg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Salbutamol Turbuhaler 100 microg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: COMPARATOR
Intervention: Salbutamol pMDI 200 microg vs pMDI 100 microg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Salbutamol pMDI 200 microg vs Turbuhaler 100 microg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Salbutamol pMDI 200 microg vs pMDI 400 microg
Number of subjects: 23
Study: 9371301

Group type: EXPERIMENTAL
Intervention: Intravenous heparin administered using a validated protocol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninvasive strategy for patients with clinically suspected pulmonary embolism
Number of subjects: 0
Study: 2701030

Group type: EXPERIMENTAL
Intervention: Doxofylline 200 mg sachets, administered at a daily dose of 12 mg/kg for 14 days.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1139016

Group type: EXPERIMENTAL
Intervention: Conditioning group (using BH onset as an unconditioned stimulus)
Number of subjects: 0
Study: 31939496

Group type: EXPERIMENTAL
Intervention: 10% DOX + scaling and root planning (SRP)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 10% DOX /β‐CD + SRP
Number of subjects: 33

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 33
Study: 31278695

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Predefined thresholds of synovitis ≤3, osteitis ≤3, and total inflammation score ≤9
Number of subjects: 351
Study: 28843636

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo Control
Number of subjects: 22
Study: 25995511

Group type: EXPERIMENTAL
Intervention: Continuing Professional Development (CPD) training
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 72
Study: 23929928

Group type: EXPERIMENTAL
Intervention: Febuxostat (80 mg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Allopurinol (300 mg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 22178829

Group type: EXPERIMENTAL
Intervention: 4 mg rosiglitazone treatment group
Number of subjects: 92

Group type: COMPARATOR
Intervention: Lifestyle adjustment group
Number of subjects: 92

Group type: COMPARATOR
Intervention: Impaired glucose tolerance group (Group B)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Type 2 diabetes group (Group C)
Number of subjects: 92
Study: 19368508

Group type: EXPERIMENTAL
Intervention: Plant-based dietary intervention (Coronary Health Improvement Project)
Number of subjects: 0
Study: 16238680

Group type: EXPERIMENTAL
Intervention: Atorvastatin or simvastatin therapy
Number of subjects: 134
Study: 12094118

Group type: EXPERIMENTAL
Intervention: Breathe Right (BR) external nasal dilator
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Normal nasal ventilation (N)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No nasal ventilation (using a nose clip) (NC)
Number of subjects: 10
Study: 10210737

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (2 effervescent tablets of 400 mg)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Paracetamol (2 effervescent tablets of 500 mg)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo (2 effervescent tablets)
Number of subjects: 600
Study: 7597268

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 1708032

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Thiazide diuretics
Number of subjects: 3234
Study: 295279

Group type: EXPERIMENTAL
Intervention: Oxazepam 30 mg for one week
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo for one week
Number of subjects: 22
Study: 31126887

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DCB
Number of subjects: 120

Group type: COMPARATOR
Intervention: DES
Number of subjects: 120
Study: 27375293

Group type: EXPERIMENTAL
Intervention: Time in the waiting room
Number of subjects: 36437

Group type: EXPERIMENTAL
Intervention: Nurse time with the patient
Number of subjects: 36437

Group type: EXPERIMENTAL
Intervention: Physician time with the patient
Number of subjects: 36437

Group type: EXPERIMENTAL
Intervention: Total time for a PC encounter
Number of subjects: 36437

Group type: EXPERIMENTAL
Intervention: Factors affecting wait times
Number of subjects: 36437

Group type: EXPERIMENTAL
Intervention: Factors affecting clinician time
Number of subjects: 36437

Group type: EXPERIMENTAL
Intervention: Late check-in and same-day visits
Number of subjects: 36437
Study: 25773354

Group type: EXPERIMENTAL
Intervention: FE 999049 (rFSH) administered subcutaneously at doses of 37.5, 75, 150, 225, or 450 IU
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: FE 999049 (rFSH) administered subcutaneously
Number of subjects: 79
Study: 23379631

Group type: EXPERIMENTAL
Intervention: Ozone exposure (60 ppb) in persistent asthmatic children with low vitamin C intake and GSTM1 null genotype
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Ozone exposure (60 ppb) in persistent asthmatic children with 4 to 6 risk alleles and low vitamin C intake
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Ozone exposure (60 ppb) in children with 1 to 3 risk alleles
Number of subjects: 257
Study: 22278799

Group type: EXPERIMENTAL
Intervention: Skull Grip
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional sutures (Prolene 0.0)
Number of subjects: 16
Study: 19439641

Group type: EXPERIMENTAL
Intervention: Dry air chilling (AC) at 0.7 degrees C for 150 min
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Immersion chilling (IC) at 0.3 degrees C for 50 min
Number of subjects: 108

Group type: COMPARATOR
Intervention: No chilling (immediate removal upon arrival)
Number of subjects: 108
Study: 17373904

Group type: EXPERIMENTAL
Intervention: Interferon-β1a
Number of subjects: 0
Study: 15473455

Group type: EXPERIMENTAL
Intervention: Large-diameter pan (220 mm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Small-diameter pan (165 mm)
Number of subjects: 20
Study: 11573637

Group type: EXPERIMENTAL
Intervention: Heparinase-modified thrombelastography algorithm
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clinical criteria and laboratory-based tests
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Algorithm group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clinically managed group
Number of subjects: 60
Study: 9577233

Group type: EXPERIMENTAL
Intervention: Selection policies with merit considerations central to decision-making (Study 1)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Selection policies without clear merit considerations (Study 2)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Work-related reactions of nonbeneficiaries (Study 3)
Number of subjects: 225
Study: 8161957

Group type: EXPERIMENTAL
Intervention: Experienced operator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inexperienced operator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Measurement procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Day-to-day variations within subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inter-subject differences
Number of subjects: 0
Study: 3202132

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) 300 mg daily for 4 weeks
Number of subjects: 128

Group type: COMPARATOR
Intervention: Betahistine 36 mg daily for 4 weeks
Number of subjects: 128
Study: 30608607

Group type: EXPERIMENTAL
Intervention: B-Sure (online decision support aid)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 93
Study: 28983961

Group type: EXPERIMENTAL
Intervention: Indoor PM2.5 levels measured using MiniVol samplers for a period of 24 hours.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Household characteristics and activities (crowding, dwelling type, household emissions from incense, candles, cooking, and household smoking practices).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Room magnitude and natural ventilation factors.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predictive model for PM2.5 levels.
Number of subjects: 0
Study: 27829405

Group type: EXPERIMENTAL
Intervention: Professional development for educators to reduce sitting time during ECEC services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25896182

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FO) 10 g daily for 12 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Corn oil (CO) 10 g daily for 12 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FO)
Number of subjects: 15
Study: 23594410

Group type: EXPERIMENTAL
Intervention: Houvast (strengths based method)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 251
Study: 20940193

Group type: EXPERIMENTAL
Intervention: Full screening (DT, problem checklist, Psychological Screen for Cancer part C, personalized report, report on medical file)
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Triage (full screening plus optional personalized phone triage)
Number of subjects: 1134

Group type: COMPARATOR
Intervention: Minimal screening (DT only plus usual care)
Number of subjects: 1134
Study: 18773724

Group type: EXPERIMENTAL
Intervention: Offsetting the stripes in the window
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manipulating the outline (no outline, black outline, red outline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test-stripe offset manipulation
Number of subjects: 0
Study: 16025252

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 4458

Group type: COMPARATOR
Intervention: Metformin or Sulphonylurea (non-rosiglitazone group)
Number of subjects: 4458
Study: 12500996

Group type: EXPERIMENTAL
Intervention: Rockport one‐mile walk test equation
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: New regression model for predicting peak oxygen uptake (VO2peak) from a one‐mile treadmill walk
Number of subjects: 304
Study: 10515287

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg)
Number of subjects: 0
Study: 7746913

Group type: EXPERIMENTAL
Intervention: Immunotherapy with Mycobacterium vaccae
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (chemotherapy alone)
Number of subjects: 0
Study: 2139286

Group type: EXPERIMENTAL
Intervention: Recombinant DNA hepatitis B vaccine alone (10 micrograms)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Recombinant DNA hepatitis B vaccine + hepatitis B immune globulin (HBIg) (10 micrograms + 0.5 ml HBIg)
Number of subjects: 58
Study: 6993109

Group type: EXPERIMENTAL
Intervention: Sulphadiazine 225 mg and Trimethoprim 75 mg (SD/TMP)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sulphamethoxazole 400 mg and Trimethoprim 80 mg (SM/TMP)
Number of subjects: 200
Study: 30982549

Group type: EXPERIMENTAL
Intervention: Small stent diameter (SD ≤ 2.75 mm)
Number of subjects: 6413

Group type: EXPERIMENTAL
Intervention: Intermediate stent diameter (2.75 mm < SD ≤ 3.25 mm)
Number of subjects: 6413

Group type: EXPERIMENTAL
Intervention: Large stent diameter (SD ≥ 3.25 mm)
Number of subjects: 6413

Group type: EXPERIMENTAL
Intervention: Early-generation drug-eluting stents (DES)
Number of subjects: 6413

Group type: EXPERIMENTAL
Intervention: New-generation drug-eluting stents (DES)
Number of subjects: 6413
Study: 28844494

Group type: EXPERIMENTAL
Intervention: Nasal corticosteroids (NCS) for 12 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Radiofrequency (RF) application
Number of subjects: 82
Study: 26298752

Group type: EXPERIMENTAL
Intervention: endurance training + kefir beverage
Number of subjects: 67

Group type: COMPARATOR
Intervention: endurance training + control beverage
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: active control + kefir beverage
Number of subjects: 67

Group type: COMPARATOR
Intervention: active control + control beverage
Number of subjects: 67
Study: 23648219

Group type: EXPERIMENTAL
Intervention: Intravenous sodium nitrite administration prior to percutaneous coronary intervention (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous sodium nitrite administration
Number of subjects: 0
Study: 21663644

Group type: EXPERIMENTAL
Intervention: DNA isolation using QIAGEN automated protocols, specifically the Compromised Blood Protocol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Age of participant at blood draw
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DNA quality assessment via gel electrophoresis QC and TaqMan genotyping
Number of subjects: 120
Study: 19539142

Group type: EXPERIMENTAL
Intervention: Exercise training (n = 25), 3 visits/week for 3 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n = 25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Exercise training (n = 25)
Number of subjects: 50